Refreshed Board Overseeing Successful
Execution of Company's Strategy
Ortelius' Candidates Bring No Additive
Experience or Insights
Urges Shareholders to Vote "FOR" ONLY
Brookdale's Eight Highly Qualified and Experienced Director
Nominees on the BLUE Proxy Card
NASHVILLE, Tenn., May 29, 2025
/PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD)
("Brookdale" or the "Company") today announced that it has mailed a
letter to Brookdale shareholders in connection with its 2025 Annual
Meeting of Stockholders (the "Annual Meeting"), which will be held
on July 11, 2025.
The letter highlights Brookdale's refreshed and well-rounded
Board, composed of eight highly-qualified director nominees, each
of whom bring the expertise and skills necessary to deliver
positive financial and operational performance and drive enhanced
shareholder value. As described in the letter, the nominees
proposed by Pangaea Ventures, L.P., a fund managed by Ortelius
Advisors, L.P. ("Ortelius"), stand in stark contrast, lacking track
records of value creation or relevant expertise that could add
value to the Brookdale Board.
The Board urges shareholders to protect the value of their
investment and vote on the BLUE proxy card today "FOR"
ONLY Brookdale's eight nominees.
The full text of the letter to shareholders follows and can also
be found at VoteBrookdaleBLUE.com.
Dear Fellow Shareholder,
At this year's Annual Meeting of Stockholders, Ortelius
Advisors, L.P. ("Ortelius"), who beneficially owns just 1% of
Brookdale's shares, is seeking to take control of your Board by
replacing six of Brookdale's eight highly qualified directors.
To enhance value for all Brookdale shareholders, the Brookdale
Board is overseeing the execution of a clear strategy, conducting a
search process for the Company's next CEO, and has significantly
refreshed your Board's composition. In contrast, Ortelius is trying
to seize control of the Brookdale Board with nominees whose skills
are not additive or relevant and is proposing strategic actions,
the majority of which Brookdale already has implemented. We believe
that electing the Ortelius nominees would undermine the substantial
progress we have made and put your investment at significant
risk.
The Board is committed to advancing the Company's strategy and
believes that replacing any of Brookdale's director nominees at
this pivotal time for the Company would significantly impair our
success and ability to identify a new CEO and create value for all
shareholders.
We urge you to vote "FOR" ONLY Brookdale's eight
highly qualified director nominees on the BLUE proxy card.
Your Board is Refreshed and
Relevant;
Best-Practice Corporate Governance Standards
Drive Greater Accountability to Shareholders
In the past year, Brookdale has added four new directors to its
Board, with strong real estate, healthcare, operations, and senior
housing experience: Joshua Hausman,
Managing Partner at MHJ Capital Partners and former Managing
Director at Onex Partners; Mark
Fioravanti, President and CEO of Ryman Hospitality
Properties, Inc.; Claudia Drayton,
Former CFO of Quantum-Si, Inc. and Nuwellis, Inc.; and Elizabeth Mace, Former Chief Economist and
Director of Research and Analytics at the National Investment
Center for Seniors Housing & Care ("NIC"). Our Board
composition reflects a thoughtful refreshment process, which
includes identifying skillsets needed to support Brookdale's
business strategy. Our directors include operators, healthcare
leaders, investors, and real estate professionals with the relevant
expertise to exercise informed oversight of our strategy and real
estate portfolio.
Ensuring best practices in corporate governance is a top
priority for the Board. Our Board has annual elections of all
directors, policies against hedging and pledging of securities,
executive compensation that aligns with performance, fully
independent Board standing committees, a majority vote standard for
non-contested elections, regular director refreshment, no
supermajority voting requirement to approve mergers, and no
stockholder rights plan. In addition, the Board is actively
reviewing governance enhancements related to director tenure and
evaluating our performance-based long-term incentive awards program
for executives, based on investor feedback.
Brookdale's Current Board is Well-Rounded,
Well-Qualified, and Experienced;
Ortelius' Candidates
Bring No Additive Experience
Brookdale's Board is an agent for change for the benefit of all
shareholders. Following the Annual Meeting, if Brookdale's nominees
are elected, the Board will be composed of eight highly qualified
and engaged directors, seven of whom are independent, with an
average tenure of less than four years.
Your Board Nominees:
Jordan Asher, MD, MS,
Independent Director
Committees: Compensation and
Nominating & Corporate Governance
Clinical &
Executive Healthcare Leadership
Joined in 2020
- 20+ years of unique expertise in the evolving healthcare
landscape developed through leading large national healthcare
systems and both clinical training and executive leadership
experience
- Former EVP and Chief Clinical Officer of Sentara
Health
Claudia Drayton, Independent
Director
Committees: Audit (Chair) and
Investment
Healthcare & Financial
Expertise
Joined in 2024
- 20 years of operational and financial experience in healthcare
and public company board experience developed through over two
decades in leadership positions across the medical and biotech
industries
- Former CFO of Quantum-Si and Nuwellis
- NACD Certified Director1
Mark Fioravanti, Independent
Director
Hospitality & Real Estate
Visionary
Joined in 2025
- 25 years of executive-level leadership in hospitality with
significant real estate, sales, marketing, and public company board
expertise
- President & CEO of Ryman Hospitality Properties,
Inc.
Victoria Freed, Independent
Director
Committees: Compensation and Nominating &
Corporate Governance (Chair)
Expertise in Sales, Customer
Service & Marketing
Joined in 2019
- 25+ years of executive leadership and award-winning expertise
in sales, revenue management, customer service, and marketing
within the hospitality industry
- SVP of Sales, Trade Support, and Service of Royal Caribbean
International
Josh Hausman, Independent
Director
Healthcare Investor & Capital Markets
Expertise
Joined in 2025
- 20+ years of investment experience within the healthcare
industry, including facilities-based senior care and behavioral
health companies, and expertise in capital markets and corporate
finance
- Former Managing Director of Onex Partners
Elizabeth Mace, Independent
Director
Committees: Audit and
Investment
Senior Housing & Real Estate
Expert
Joined in 2024
- Extensive knowledge in senior housing, real estate, and 30+
years in economics and broader market analysis
- Former Chief Economist and Director of Research and Analytics
of National Investment Center for Seniors Housing & Care
(NIC)
- NACD Certified Director1
Denise Warren, Chair and
Interim CEO
Healthcare, Financial & Operations
Leadership
Joined in 2018
- 30+ years of executive, operational, and financial experience
across the healthcare industry with a track record of leadership
excellence
- Former EVP and COO of WakeMed Health & Hospitals
- NACD Certified Director1
Lee Wielansky, Independent
Director
Committees: Audit and Investment
(Chair)
Real Estate Investor Expertise
Joined
in 2015
- 40+ years of real estate investment, management, and
development experience as well as significant public board
expertise
- Chair & CEO of Opportunistic Equities
- Former Chair and CEO of Midland Development Group, Inc.
We are confident that the expertise of Brookdale's director
nominees is superior to that of the Ortelius candidates. All eight
of Brookdale's highly qualified director nominees possess the
relevant skills to further drive value creation. Their collective
backgrounds reflect an appropriate balance of healthcare, finance,
senior housing, hospitality, sales & marketing, and real estate
experience, thoughtfully constructed to represent a range of
critical and complementary skills.
In contrast, none of the Ortelius nominees have experience in
critical areas such as healthcare (clinical), hospitality, or sales
& marketing.
Steven Insoft
- Serves on an advisory board of an affiliate to Ortelius,
raising questions with respect to his independence from
Ortelius
- Experience limited to real estate investment trusts and real
estate transactions, skillsets already present on the Board
- No public company board experience
- Experience primarily in the government-reimbursed skilled
nursing industry, which represents only 2% of Brookdale's
business
Paula Poskon
- Nominated by multiple activists in several other campaigns in
recent years
- Experience primarily focused on REITs, which is already
well-represented on our current Board
- No apparent experience in senior living or public company
C-suite roles
Frank Small
- Redundant private equity and real estate skillsets that already
exist on Brookdale's Board
- Experience primarily in real estate investments and
transactions
- No apparent management or board experience in senior
living
- No public company board or C-suite experience
Ivona Smith
- Expertise in restructurings and liquidation trusts, which are
irrelevant and not needed at Brookdale
- Repeatedly nominated by Ortelius in other activist campaigns –
raises risk that her allegiance will be to Ortelius and not all
shareholders
- Currently serves as a director of two public companies and five
private companies, raising concerns about her capacity to
meaningfully contribute to the Brookdale Board
Steven Vick
- Previously served as President & COO and a Director of
Alterra Healthcare, but left shortly prior to its bankruptcy
- No relevant public company experience in 20 years
- Unclear track record during recent leadership roles at private
companies
Lori Wittman
- Non-operational experience in real estate focused largely on
financial management
- No operational experience in healthcare or senior living
- Limited exposure to seniors housing through Finance and IR
roles at REITs
We strongly believe it is in shareholders' best interests to NOT
bring Ortelius' nominees or self-serving agenda into the boardroom.
We believe that further Board change at this time will derail the
Board's progress and significantly impair the Board's ability to
identify a new CEO and continue executing our strategy at a
critical time for the Company.
Ortelius Has Made Little Effort to Better
Understand Brookdale's Recent Improvements
or to
Demonstrate Why Their Nominees Could Be Additive to the
Board
Your Board has made multiple attempts to engage with Ortelius to
avoid this proxy contest. Ortelius has shown little interest in
working together constructively and refused to allow the Board to
even interview any of its nominees. Rather than participating in
mutual problem-solving with Brookdale, Ortelius has continued
issuing public attacks and demands in pursuance of its misguided
campaign to take control of your Company.
Ortelius apparently would rather ignore the actions Brookdale
has taken to improve operating metrics and the successful execution
of our key initiatives: improving operating performance, optimizing
our real estate portfolio, reinvesting capital into our
communities, reducing our leverage, and ensuring high-quality
environments for our residents and associates. The results that we
achieved in the first quarter of 2025 reflect that our actions are
working and already driving shareholder value creation:
- Positive Adjusted Free Cash Flow2, which has
typically been negative in the first quarter
- Adjusted EBITDA2 that exceeded internal
expectations and consensus estimates
- 80% same community weighted average occupancy, which was
sequentially flat and a key turning point towards positive cash
flow generation
- 140 bps increase in consolidated weighted average
occupancy YoY3
- 4.9% growth in consolidated RevPAR YoY, exceeding internal
expectations
- 90 bps expansion in same community operating income margin
YoY – delivering the highest same community operating income margin
achievement in five years
Ortelius' Imprecise Comparisons and Convenient
Omission
In criticizing the Company's performance, Ortelius omits the
most obvious public company comparison, Sonida Senior Living, Inc. ("Sonida"), which
Brookdale has outperformed4. Sonida is the only other
publicly traded senior living operating company in the U.S.
Further, Sonida has a similar portfolio mix to Brookdale with asset
categories across assisted living, independent living, and memory
care. Sonida's payor mix is also weighted towards private pay,
which is similar to Brookdale. We believe it is telling that
Ortelius makes no mention of Sonida in any of its communications to
shareholders to date.
Instead, Ortelius compares Brookdale to Welltower Inc.
("Welltower") and Ventas, Inc. ("Ventas"), which differ from
Brookdale due to their size, scale, and product mix. Importantly,
as highly diversified healthcare real estate investment trusts
(REITs), Welltower and Ventas also own real estate in other areas
of healthcare services and are materially larger companies than
Brookdale. Shareholders should be aware that only portions of
Welltower's and Ventas' portfolios are in senior housing. Notably,
in the first quarter of 2025, Brookdale outperformed Welltower and
Ventas in same community operating income growth and same community
RevPAR growth on a sequential quarter basis.
Vote the BLUE Proxy Card TODAY "FOR" ONLY
Brookdale's Eight Nominees
The Brookdale Board is best suited to oversee and advance the
Company's strategy and initiatives, with the expertise and skills
necessary to continue delivering positive financial and operational
performance and driving enhanced shareholder value. Do not let
Ortelius distract you from the progress the Board is making and
jeopardize the long-term potential of your investment by replacing
any of your highly qualified directors at this crucial time. Your
Board has been open-minded and responsive to shareholder input. We
do not believe the changes to the Board proposed by Ortelius are in
the best interests of the Company or our shareholders.
Protect the value of your investment and vote the BLUE proxy
card today "FOR" ONLY Brookdale's highly qualified and experienced
director nominees.
Thank you for your continued support.
Sincerely,
The Brookdale Board of Directors
YOUR VOTE IS EXTREMELY IMPORTANT, NO MATTER
HOW MANY SHARES YOU OWN
Whether or not you expect to attend the Annual
Meeting, please promptly follow the easy instructions on
your BLUE proxy card
or BLUE voting instruction form to vote by phone,
internet or by signing, dating, and returning
the BLUE proxy card in the postage-paid envelope
provided.
Please simply disregard any white proxy card you
may receive from Ortelius.
If you have any questions or require
assistance in voting your shares,
please call Brookdale's proxy solicitor:
INNISFREE M&A INCORPORATED
Shareholders may call:
+ 1 (877) 750-5838 (toll-free from the U.S. and
Canada) or
+1 (412) 232-3651 (from other countries)
NON-GAAP FINANCIAL MEASURES
This communication
mentions the financial measures Adjusted EBITDA and Adjusted Free
Cash Flow, which are not calculated in accordance with U.S.
generally accepted accounting principles ("GAAP"). Reference to
these non-GAAP financial measures is intended to aid investors in
better understanding the factors and trends affecting the Company's
performance and liquidity. However, investors should not consider
these non-GAAP financial measures as a substitute for financial
measures determined in accordance with GAAP, including net income
(loss), income (loss) from operations, or net cash provided by
(used in) operating activities.
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP
performance measure that the Company defines as net income (loss)
excluding: benefit/provision for income taxes, non-operating
income/expense items, and depreciation and amortization; and
further adjusted to exclude income/expense associated with
non-cash, non-operational, transactional, legal, cost reduction, or
organizational restructuring items that management does not
consider as part of the Company's underlying core operating
performance and that management believes impact the comparability
of performance between periods.
The Company believes that presentation of Adjusted EBITDA as a
performance measure is useful to investors because (i) it is one of
the metrics used by the Company's management for budgeting and
other planning purposes, to review the Company's historic and
prospective core operating performance, and to make day-to-day
operating decisions; (ii) it provides an assessment of operational
factors that management can impact in the short-term, namely
revenues and the controllable cost structure of the organization,
by eliminating items related to the Company's financing and capital
structure and other items that management does not consider as part
of the Company's underlying core operating performance and that
management believes impact the comparability of performance between
periods; (iii) the Company believes that this measure is used by
research analysts and investors to evaluate the Company's operating
results and to value companies in its industry; and (iv) the
Company uses the measure for components of executive
compensation.
Adjusted Free Cash Flow
Adjusted Free Cash Flow
is a non-GAAP liquidity measure that the Company defines as net
cash provided by (used in) operating activities before:
distributions from unconsolidated ventures from cumulative share of
net earnings, changes in prepaid insurance premiums financed with
notes payable, changes in operating lease assets and liabilities
for lease termination, cash paid/received for gain/loss on facility
operating lease termination, and lessor capital expenditure
reimbursements under operating leases; plus: property and casualty
insurance proceeds and proceeds from refundable entrance fees, net
of refunds; less: non-development capital expenditures and payment
of financing lease obligations.
The Company believes that presentation of Adjusted Free Cash
Flow as a liquidity measure is useful to investors because (i) it
is one of the metrics used by the Company's management for
budgeting and other planning purposes, to review the Company's
historic and prospective sources of operating liquidity, and to
review the Company's ability to service its outstanding
indebtedness, pay dividends to stockholders, engage in share
repurchases, and make capital expenditures, including development
capital expenditures; and (ii) it provides an indicator to
management to determine if adjustments to current spending
decisions are needed.
DEFINITIONS
RevPAR, or average monthly senior
housing resident fee revenue per available unit, is defined by the
Company as resident fee revenue for the corresponding portfolio for
the period (excluding revenue for private duty services provided to
seniors living outside of the Company's communities and entrance
fee amortization), divided by the weighted average number of
available units in the corresponding portfolio for the period,
divided by the number of months in the period.
RevPOR, or average monthly senior housing resident fee
revenue per occupied unit, is defined by the Company as resident
fee revenue for the corresponding portfolio for the period
(excluding revenue for private duty services provided to seniors
living outside of the Company's communities), divided by the
weighted average number of occupied units in the corresponding
portfolio for the period, divided by the number of months in the
period.
Operating Income is defined by the Company as
resident fee revenue and other operating income less facility
operating expense. Operating Income does not include general and
administrative expense or depreciation and amortization.
Operating Income Margin is defined by the Company as
Operating Income divided by resident fee revenue.
Same Community information reflects operating
results and data of a consistent population of communities by
excluding the impact of changes in the composition of the Company's
portfolio of communities. The operating results exclude natural
disaster expense and related insurance recoveries. The Company
defines its same community portfolio as communities consolidated
and operational for the full period in both comparison years.
Consolidated communities excluded from the same community portfolio
include communities acquired or disposed of since the beginning of
the prior year, communities classified as assets held for sale,
certain communities planned for disposition including through asset
sales or lease terminations, certain communities that have
undergone or are undergoing expansion, redevelopment, and
repositioning projects, and certain communities that have
experienced a casualty event that significantly impacts their
operations.
Same Community Operating Income is defined by the Company
as resident fee revenue less facility operating expense (excluding
natural disaster expense and related insurance recoveries) for the
Company's Same Community portfolio. Same Community Operating Income
does not include general and administrative expense or depreciation
and amortization.
ABOUT BROOKDALE SENIOR LIVING
Brookdale Senior
Living Inc. is the nation's premier operator of senior living
communities. With 647 communities across 41 states and the ability
to serve approximately 58,000 residents as of March 31, 2025, Brookdale is
committed to its mission of enriching the lives of seniors through
compassionate care, clinical expertise, and exceptional service.
The Company, through its affiliates, operates independent living,
assisted living, memory care, and continuing care retirement
communities, offering tailored solutions that help empower seniors
to live with dignity, connection, and purpose. Leveraging deep
expertise in healthcare, hospitality, and real estate,
Brookdale creates opportunities for wellness, personal
growth, and meaningful relationships in settings that feel like
home. Guided by its four cornerstones of passion, courage,
partnership, and trust, Brookdale is committed to
delivering exceptional value and redefining senior living for a
brighter, healthier future. Brookdale's stock trades
on the New York Stock Exchange under the ticker symbol
BKD. For more information, visit brookdale.com
or connect with Brookdale on Facebook
or YouTube.
FORWARD-LOOKING STATEMENTS
Certain statements in this
communication may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are subject to various risks and
uncertainties and include all statements that are not historical
statements of fact and those regarding the Company's intent,
belief, or expectations. Forward-looking statements are generally
identifiable by use of forward-looking terminology such as "may,"
"will," "should," "could," "would," "potential," "intend,"
"expect," "endeavor," "seek," "anticipate," "estimate," "believe,"
"project," "predict," "continue," "plan," "target," or other
similar words or expressions, and include statements regarding the
focus of the Board of Directors and management of the Company, the
execution and advancement of the Company's strategy, the Company's
ability to continue to successfully execute on key initiatives,
deliver positive financial and operational performance and drive
enhanced shareholder value. These forward-looking statements are
based on certain assumptions and expectations, and the Company's
ability to predict results or the actual effect of future plans or
strategies is inherently uncertain. Although the Company believes
that expectations reflected in any forward-looking statements are
based on reasonable assumptions, it can give no assurance that its
assumptions or expectations will be attained and actual results and
performance could differ materially from those projected. Factors
which could have a material adverse effect on the Company's
operations and future prospects or which could cause events or
circumstances to differ from the forward-looking statements
include, but are not limited to, events which adversely affect the
ability of seniors to afford resident fees, including downturns in
the economy, housing market, consumer confidence, or the equity
markets and unemployment among resident family members; the effects
of senior housing construction and development, lower industry
occupancy, and increased competition; conditions of housing
markets, regulatory changes, acts of nature, and the effects of
climate change in geographic areas where the Company is
concentrated; terminations of the Company's resident agreements and
vacancies in the living spaces it leases; changes in reimbursement
rates, methods, or timing under governmental reimbursement programs
including the Medicare and Medicaid programs; failure to maintain
the security and functionality of the Company's information
systems, to prevent a cybersecurity attack or breach, or to comply
with applicable privacy and consumer protection laws, including
HIPAA; the Company's ability to complete its capital expenditures
in accordance with its plans; the Company's ability to identify and
pursue development, investment, and acquisition opportunities and
its ability to successfully integrate acquisitions; competition for
the acquisition of assets; the Company's ability to complete
pending or expected disposition, acquisition, or other transactions
on agreed upon terms or at all, including in respect of the
satisfaction of closing conditions, the risk that regulatory
approvals are not obtained or are subject to unanticipated
conditions, and uncertainties as to the timing of closing, and the
Company's ability to identify and pursue any such opportunities in
the future; risks related to the implementation of the Company's
strategy, including initiatives undertaken to execute on the
Company's strategic priorities and their effect on its results; any
resurgence or variants of the COVID-19 pandemic; limits on the
Company's ability to use net operating loss carryovers to reduce
future tax payments; delays in obtaining regulatory approvals; the
risks associated with tariffs and the uncertain duration of trade
conflicts; disruptions in the financial markets or decreases in the
appraised values or performance of the Company's communities that
affect the Company's ability to obtain financing or extend or
refinance debt as it matures and the Company's financing costs; the
Company's ability to generate sufficient cash flow to cover
required interest, principal, and long-term lease payments and to
fund its planned capital projects; the effect of any non-compliance
with any of the Company's debt or lease agreements (including the
financial or other covenants contained therein), including the risk
of lenders or lessors declaring a cross default in the event of the
Company's non-compliance with any such agreements and the risk of
loss of the Company's property securing leases and indebtedness due
to any resulting lease terminations and foreclosure actions; the
inability to renew, restructure, or extend leases, or exercise
purchase options at or prior to the end of any existing lease term;
the effect of the Company's indebtedness and long-term leases on
the Company's liquidity and its ability to operate its business;
increases in market interest rates that increase the costs of the
Company's debt obligations; the Company's ability to obtain
additional capital on terms acceptable to it; departures of key
officers and potential disruption caused by changes in management;
increased competition for, or a shortage of, associates, wage
pressures resulting from increased competition, low unemployment
levels, minimum wage increases and changes in overtime laws, and
union activity; environmental contamination at any of the Company's
communities; failure to comply with existing environmental laws; an
adverse determination or resolution of complaints filed against the
Company, including putative class action complaints; negative
publicity with respect to any lawsuits, claims, or other legal or
regulatory proceedings; costs to respond to, and adverse
determinations resulting from, government inquiries, reviews,
audits, and investigations; the cost and difficulty of complying
with increasing and evolving regulation, including new disclosure
obligations; changes in, or its failure to comply with,
employment-related laws and regulations; the risks associated with
current global economic conditions and general economic factors on
the Company and the Company's business partners such as inflation,
commodity costs, fuel and other energy costs, competition in the
labor market, costs of salaries, wages, benefits, and insurance,
interest rates, tax rates, tariffs, geopolitical tensions or
conflicts, and uncertainty surrounding a new presidential
administration, the impact of seasonal contagious illness or other
contagious disease in the markets in which the Company operates;
actions of activist stockholders, including as a result of the
current proxy contest and any potential change of control of the
Company or the Board; as well as other risks detailed from time to
time in the Company's filings with the Securities and Exchange
Commission ("SEC"), including those set forth in the Company's
Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. When
considering forward-looking statements, you should keep in mind the
risk factors and other cautionary statements in such SEC filings.
Readers are cautioned not to place undue reliance on any of these
forward-looking statements, which reflect management's views as of
the date of this communication. The Company cannot guarantee future
results, levels of activity, performance or achievements, and,
except as required by law, it expressly disclaims any obligation to
release publicly any updates or revisions to any forward-looking
statements contained in this communication to reflect any change in
the Company's expectations with regard thereto or change in events,
conditions, or circumstances on which any statement is based.
CONTACTS
Investors
Jessica
Hazel
VP Investor Relations
(615) 564-8104
Jessica.Hazel@brookdale.com
Media
media.relations@brookdale.com
Tim Lynch / Leigh Parrish
Joele Frank, Wilkinson Brimmer
Katcher
(212) 355-4449
1 National Association of Corporate Directors
Directorship Certified(TM)
2 See Non-GAAP
Financial Measures below for further information
3 Year over Year
4 Based on Brookdale and Sonida's stock price
performance over time as of 05/02/2025 (1.9% for 6-year, 5.1% for 3-year,
-12.1% for 1-year and 30.8% YTD performance for Brookdale and
-58.4% for 6-year, -21.5% for 3-year, -27.9% for 1-year and 4.3%
YTD performance for Sonida)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/brookdale-showcases-the-strength-and-effectiveness-of-current-board-of-directors-302468200.html
SOURCE Brookdale Senior Living Inc.